Plus   Neg

Stock Alert: Moderna Jumps 16% As Covid Vaccine 94.1% Effective; To Apply For Emergency Use

Shares of Moderna, Inc. (MRNA) are rising more than 16% Monday morning after the company said it is planning to apply for U.S and European Emergency approval of its Covid-19 vaccine mRNA-1273, as its late study showed that the vaccine candidate is 94.1% effective to prevent the disease.

The stock touched a new high of $150 this morning

The company on Monday said it plans to apply for Emergency Use Authorization (EUA) from the U.S. FDA and conditional approval from the European Medicines Agency (EMA).

The company also reported vaccine efficacy against severe Covid-19 was 100%.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Rapala USA has recalled about 128,000 units of Rechargeable Fillet Knives due to fire hazard, according to the U.S. Consumer Product Safety Commission. The recall involves the Rapala Rechargeable Fillet Knife with item number RRFN. The knife handles are black and gray, and the Rapala logo is printed in red on the handle, along with the word ION in white. Facebook said it has launched an improved version of its automatic alternative text or AAT feature to improve photo descriptions for its users who are blind or visually impaired. AAT utilizes object recognition to generate descriptions of photos on demand so that blind or visually impaired, or BVI individuals, can more fully enjoy their News Feed. Morgan Stanley (MS) reported Wednesday a profit for the fourth-quarter that climbed 57 percent from last year, reflecting strong performance across all three business segments. Both earnings per share and quarterly revenue beat analysts' estimates.
Follow RTT